Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
about
Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder.Genital tuberculosis: current status of diagnosis and management.Mycobacteria Bovis osteomyelitis following intravesical BCG for bladder cancer.
P2860
Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
@ast
Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
@en
Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
@nl
type
label
Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
@ast
Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
@en
Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
@nl
prefLabel
Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
@ast
Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
@en
Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
@nl
P2860
P3181
P356
P1476
Managing the adverse events of intravesical bacillus Calmette-Guérin therapy
@en
P2093
Karel Decaestecker
Willem Oosterlinck
P2860
P304
P3181
P356
10.2147/RRU.S63448
P407
P577
2015-01-01T00:00:00Z